Clinical Trials Logo

Pre-hypertension clinical trials

View clinical trials related to Pre-hypertension.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05892328 Recruiting - Clinical trials for Cardiovascular Diseases

Watermelon Dose Response Blood Pressure Study

WMBP
Start date: April 7, 2023
Phase: N/A
Study type: Interventional

1. Primary outcome: To evaluate the dose response effects of watermelon flesh in regulating Blood Pressure (BP) in individuals with pre-hypertension. 2. Secondary outcomes: To study the dose-response effects of watermelon flesh intake on cardio-metabolic risk factors including plasma metabolic markers, lipid profile and nitrate/nitrite levels in individuals with pre-hypertension.

NCT ID: NCT04543656 Recruiting - Pre-hypertension Clinical Trials

Personalized Blood Pressure Care Using IoMTs and Artificial Intelligence

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

In this RCT, up to 100 adults classified as pre-hypertensive will be randomized to either an artificial intelligence (AI) based lifestyle intervention group or an active control group with a 1 to 1 ratio. Both groups will receive an identical activity tracker (Samsung Galaxy Watch) and BP monitor (Omron Evolv). The AI intervention group will receive automated and personalized lifestyle recommendations based on their lifestyle (e.g. sleep, exercise and diet) and blood pressure (BP) data, involving an automated analytics engine using statistics and machine learning. The active control group will not receive these lifestyle recommendations. The investigators aim to assess objectively the effectiveness of the AI-based personalized lifestyle recommendations on the patients BP.